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Abstract 
 
The solution and complexation chemistry of zinc ions is the basis for zinc biology.  In living 
organisms, zinc is redox-inert and has only one valence state: Zn(II).  Its coordination 
environment in proteins is limited by oxygen, nitrogen, and sulfur donors from the side chains of 
a few amino acids.  In an estimated 10% of all human proteins, zinc has a catalytic or structural 
function and remains bound during the lifetime of the protein.  However, in other proteins zinc 
ions bind reversibly with dissociation and association rates commensurate with the requirements 
in regulation, transport, transfer, sensing, signalling, and storage.  In contrast to the extensive 
knowledge about zinc proteins, the coordination chemistry of the “mobile” zinc ions in these 
processes, i.e. when not bound to proteins, is virtually unexplored and the mechanisms of ligand 
exchange are poorly understood.  Knowledge of the biological inorganic chemistry of zinc ions 
is essential for understanding its cellular biology and for designing complexes that deliver zinc to 
proteins and chelating agents that remove zinc from proteins, for detecting zinc ion species by 
qualitative and quantitative analysis, and for proper planning and execution of experiments 
involving zinc ions and nanoparticles such as zinc oxide (ZnO).  In most investigations, 
reference is made to zinc or Zn2+ without full appreciation of how biological zinc ions are 
buffered and how the d-block cation Zn2+ differs from s-block cations such as Ca2+ with regard 
to significantly higher affinity for ligands, preference for the donor atoms of ligands, and 
coordination dynamics.  Zinc needs to be tightly controlled.  The interaction with low molecular 
weight ligands such as water and inorganic and organic anions is highly relevant to its biology 
but in contrast to its coordination in proteins has not been discussed in the biochemical literature.  
From the discussion in this article, it is becoming evident that zinc ion speciation is important in 
zinc biochemistry and for biological recognition as a variety of low molecular weight zinc 
complexes have already been implicated in biological processes, e.g. with ATP, glutathione, 
citrate, ethylenediaminedisuccinic acid, nicotianamine, or bacillithiol. 
 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
 
1. Introduction 
Proteins are the major ligands for zinc(II) ions (“zinc”).  Zinc can be readily available from 
proteins or not available at all unless the protein is degraded.  In a way, the coordination 
chemistry of zinc in proteins bridges the one in natural waters, where zinc is in an available 
form, and the one in minerals, where zinc is unavailable without chemical processing.  Zinc is 
essential for virtually all cellular functions through its presence in an estimated 3000 human 
proteins, the zinc sites of which have been predicted by bioinformatics approaches from the 
signature motifs in their protein sequences [1].  If one considers additional functions of zinc in 
regulation, the number of zinc proteins in the human zinc proteome will be even larger [2].  The 
coordination chemistry of zinc in proteins and peptides involves N, O, and S donors of the side 
chains of histidine, glutamate/aspartate, and/or cysteine with any permutation of these ligands 
and with the number of protein ligands ranging from three to six.  The ligands may not stem 
from a single protein but from up to four proteins.  One property regularly cited for zinc is its 
flexibility in coordination due to the lack of ligand field stabilization.  This allows for dynamic 
coordination environments of zinc, which is critical for example in its catalytic prowess in 
enzymes when adopting different coordination numbers in interactions with substrates.  A 
critical chemical issue that is important for the functions of proteins is their affinity towards zinc.  
Using a limited number of ligand donors and geometries, proteins must control and adjust 
affinities for zinc according to physiological functions. These functions are determined by the 
structural properties of zinc binding sites such as the presence of a second coordination sphere 
that engages in hydrogen bonding to ligands, including water molecules when present, geometric 
strains (entasis), pockets with different dielectric constants (hydrophobic cores), all of which 
modulate the properties of the bound zinc. For example, in zinc fingers with a ββα fold and in 
zinc-containing LIM domains, hydrogen bonds and hydrophobic and electrostatic interactions 
around the bound zinc affect binding and exchange kinetics [3,4].  Such stabilization through 
interactions in the second coordination sphere, though not always directly obvious from 
inspection of the protein structure, occurs in both intra- or intermolecular zinc binding sites and 
is responsible for stabilizing some sites to affinities for zinc as high as femtomolar in zinc-
binding domains such as the zinc hook [5].  A lack or a limited number of stabilizing secondary 
interactions also can have the opposite effect, namely decreasing affinities of proteins for zinc as 
a way of controlling their function [6].  Zinc coordination in proteins has been reviewed and 
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catalogued extensively and hence is not the subject of this article.  An important subject that has 
not been reviewed in the literature, however, is the biological coordination chemistry of zinc ions 
when not bound to proteins – the focus of this article.  This subject matter is important with 
regard to the way zinc is controlled in biology and the functions of zinc as a signalling ion as 
discussed in many articles in this special issue.   
 
2. The relationship between protein-bound and “free zinc” and the role of zinc ions in 
cellular signalling 
Biologically essential divalent metal ions are regulated in cells in ranges of concentrations that 
follow the Irving-Williams series [7].  If metal ions were not buffered in certain ranges, each 
metal ion would not be capable of performing its specific functions because the coordination 
environments of proteins are not sufficiently selective for a particular metal ion.  Zinc binds with 
rather high affinities to metal sites of proteins and therefore is highly competitive towards other 
metal ions binding with lower affinities.  Characteristic for the interaction of zinc ions with 
intracellular (i) or extracellular (e) proteins (P) is an equilibrium far to the left (Eq.1).   
 
(Eq.1)                                                    ZnP     P + [Zn2+]i,e      
 
In order for zinc not to bind to metal sites for iron, for example, the concentrations of zinc ions 
must be kept sufficiently low despite the fact that total cellular zinc concentrations are rather 
high, ie. about 200 µM.  This control is achieved by buffering zinc in a range of relatively low 
pZn (-log[Zn2+]free), a situation quite different from solutions of zinc salts in water or in most 
biological buffers where zinc is not buffered.  The term “zinc buffering” is based on the pH 
buffering concept, where an appropriate pH value is controlled by the ratio between a protonated 
form (HA), formally an acid according to the Brønsted–Lowry theory, and a deprotonated form 
of the buffer component (A-), formally a base, and the acid dissociation constant of HA (pKa) 
(Eq.2, the Henderson–Hasselbalch equation).  Likewise zinc buffering and pZn are determined 
by both species of the zinc buffering components, ie. the ratio between the metallated holo-form 
of the zinc complex ZnP (if the ligand is a protein, P) and the demetallated apo-form P, and the 
dissociation constant (pKd) of the ZnP complex (Eq.3) [8].  Zinc buffering must occur in a way 
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to have most zinc enzymes 100% metallated to be functional.  In cultured HT29 colon cancer 
cells, about 10% of sites with high affinity (Kd = 83 pM) were found to be demetallated, thus 
contributing to a ~10/90% buffer ratio under these conditions [9].  
 
(Eq.2)                                             pH = p + log 
[
]
[]  
(Eq.3)                                             pZn = p + log 
 [][] 
 
The concentrations of “free” zinc ions in the cytosol of cells have been estimated to be in 
the range of a few hundred picomolar under steady-state conditions [9, 10].  They can fluctuate 
only in a rather narrow range to avoid deficiency and toxicity.  The efficient zinc buffering is 
achieved by high affinity binding to proteins and transport processes that also control the 
concentrations of zinc.  In order to allow for and control pre-steady state fluctuations of zinc 
ions, an additional process participates, namely the transport of excess zinc ions into a 
subcellular store.  This kinetic process contributes to thermodynamic buffering and is called 
muffling [11].  A muffler binds zinc ions and transports them from the cytosol to a vesicular 
compartment where they are sequestered.  Muffling allows the cell to cope with higher zinc ion 
fluctuations without the need for high buffering capacity and makes possible zinc ion fluxes and 
signalling in an otherwise metal-buffered environment.  Buffering and muffling have a limited 
capacity.  Yet, they avoid that zinc ions reach higher concentrations to displace other metal ions 
from their binding sites or to target sites that are normally not occupied with metal ions.   
On the other hand, sufficient zinc ions must be available to supply zinc-requiring 
proteins.  Zinc is released during protein turnover, transported into the cell and out of the cell, 
and further re-distributed among cellular compartments.  The control of total and “free” zinc ion 
concentrations also involves fluctuating zinc ion concentrations that regulate biological 
processes.  Increased cellular zinc ion concentrations (“zinc ion transients” or “zinc signals”) are 
generated during mobilization of zinc ions from proteins by chemical processes that modify the 
protein or release of zinc ions from organellar/vesicular stores, where zinc is stored in a yet to be 
determined chemical form (Eq.4). 
 
(Eq.4)       ZnP → P* + [Zn2+]i,e     where P* denotes a modified protein  
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Similar to the release of calcium ions, hormones were shown to stimulate the release of zinc ions 
from the endoplasmic reticulum (ER) [12].  However, an examination of epidermal growth 
factor/ionomycin stimulated breast cancer cells employing genetically encoded FRET sensors for 
zinc could not detect the release of zinc ions [13].  Signalling with oxidative species also can 
release zinc ions from coordination environments of zinc with sulfur donors from cysteine in 
proteins, linking redox metabolism and zinc metabolism and converting redox signals into zinc 
signals [14].  While the hydrated Ca2+ ion is the major species in calcium signalling, this is not 
the case in zinc signalling as Zn2+ ion has much higher affinities for donors of ligands.   
Furthermore, some cells release zinc ions and increase extracellular zinc concentrations.  
The pool of zinc ions that is not bound to proteins is functionally significant and has been 
variously referred to as “labile zinc”, “free zinc”, “fast-exchanging zinc”, and “mobile zinc.”  All 
these operational definitions are unsatisfactory as chemical terms.  The use of these terms has 
resulted in considerable ambiguities.  In the entire biochemical literature, the zinc ions not bound 
to proteins are not specified in terms of their coordination environments.  In analogy with Ca2+ in 
biology, some investigators think of “free” zinc as its aquo complex.  The chemist understands 
“free” zinc as the ion without ligands, which exists only in the gas phase.  However, given the 
large number of potential ligands inside and outside cells, and the dynamic changes of ligands 
and zinc concentrations, non-protein bound (“free”) zinc is expected to have different types of 
LMW ligands under various biological conditions, including inorganic and organic anions, and 
in this regard it is quite different from Ca2+.  The lack of understanding the chemical nature of 
the pool of non-protein bound zinc is a major limitation in interpreting experiments and in 
planning experiments with conclusive outcomes.  In this article, we attempt to address this issue 
by discussing the solution chemistry of zinc ions and then relating it to the biological 
coordination chemistry, with an emphasis on quantitative concepts and the constraints imposed 
by cells.  This treatment results in a focus on those aspects of zinc chemistry that are important 
for biology, nutrition, pharmacology and toxicology, and for investigating the biology of zinc 
with fluorescent probes.  The characteristic coordination chemistry of zinc is a key to 
understanding its physiological and pathophysiological functions in living organisms.   
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3. Zinc speciation 
The speciation of zinc is illustrated best with a Pourbaix diagram (Figure 1).  Such a diagram 
shows chemical species as a function of both redox standard potential and pH values, and 
demonstrates a remarkable property of zinc that is critical for its functions in biology: In the 
absence of other coordinating ligands, zinc is present as hydrated Zn2+(aq), over the entire ranges 
of redox potentials and pH values in biology.  The orange arrow in Figure 1 indicates the range 
of biologically important standard potentials determined at pH 7.4.  Even for the lowest half 
reactions of the reductions of acetate to acetaldehyde (-581 mV) or succinate to α-ketoglutarate 
(-670 mV) zinc maintains its +2 oxidation state [15].  In other words, zinc is redox-inert in 
biology and therefore its redox properties are irrelevant.  Therefore, we refer to zinc in +2 
oxidation state (Zn(II)) simply to zinc in this article though this term is reserved to the element in 
the 0 oxidation state in chemistry.  In biology, many ligands are present and the species observed 
as a function of the concentrations of these ligands and pH are relevant as they modify the 
behavior of zinc ions.  The resulting implications for function are discussed in this article. 
 
3.1. Zinc(II) aquo complexes and hydroxides 
The Pourbaix diagram (Figure 1) does not imply that hydrated Zn2+(aq) is a single species.  The 
chemistry of the zinc ion in water is fundamental, rather complex, and has important 
consequences for the role of zinc in biology.  Water is both a Lewis base, coordinating as a 
ligand via its oxygen atom to the zinc ion, and a Lewis acid, coordinating to donors with 
negative charges via its hydrogen atoms.  Binding of water molecules is electrostatic in nature 
for alkali metal ions, such as Na+ and K+, but has significant covalent character for transition 
metal ions including zinc ions.  The covalent character of the zinc ion/water interaction is 
confirmed by a high heat of zinc ion solvation of ~ -500 kcal/mol in aqueous solutions [16].  
Assuming six water molecules (hexaaquo complex) bound to a central zinc ion,  the enthalpy of 
solvation for one water molecule is ~ -80 kcal/mol, which corresponds to typical values for 
covalent Zn-O bond formation (-70 – -85 kcal/mol).  
Zn2+ has a filled d-shell ([Ar]d10 electron configuration) and consequently no ligand field 
stabilization energies and associated stereochemical preferences.  Therefore, coordination 
number and geometry of zinc complexes are determined mainly by the radii of both the metal ion 
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and the coordinating ligand atoms or ions and its aquo complexes have quite flexible 
coordination geometry.  Besides the commonly described hexaaquo complex [Zn(H2O)6]2+, there 
is also a tetraaquo complex [Zn(H2O)4]2+.  In the solid state, a pentacoordinate [Zn(H2O)5]2+ 
complex has also been found [17].  Ab initio calculations show that hexa-, penta- and tetraaquo 
zinc complexes differ by less than 0.4 kcal/mol, which is contrast with other divalent cations 
such as magnesium.  It is in agreement with the biological roles of the cations.  The coordination 
of magnesium is mostly octahedral whereas zinc ions are bound to sulfur, nitrogen or oxygen 
donors with coordination dynamics linked to catalysis [18].   
Zinc aquo complexes are acids according to the Brønsted–Lowry theory.  The 
polarization of water molecules by the central zinc ion causes dissociation of a proton, resulting 
in the formation of an aquo-hydroxo complex (Eq.5).  The equation solved for the concentrations 
of protons [H3O+] is the non-logarithmic form of the Henderson-Hasselbalch equation describing 
pH buffering of a zinc salt in the range of pH within ± 1 of the pKa (pKa1 = 9.05) of hydrolysis of 
the hexaaquo complex [19] (Eq.6). 
 
(Eq.5)                         [Zn(H2O)6]2+ + H2O    [Zn(OH)(H2O)5]+ + H3O+    
 
(Eq.6)                                        [HO] =  [Zn(H2O)6]
2+
[Zn(OH)(H2O)5]+ 
 
All zinc salts of strong acids (chloride, nitrate, sulfate or perchlorate) are weak acids as indeed 
observed in pH-metric measurements.  The pH value of a solution of a zinc salt in water can be 
calculated from Eq.7, which is derived from Eq.6 under the assumptions that the concentrations 
of H3O+ and [Zn(OH)(H2O)5]+ are the same and the concentration of [Zn(H2O)6]2+ corresponds 
roughly to the total concentration (cs) of the zinc salt. 
 
(Eq.7)                                                  pH	=	0.5	p − 0.5	log(cs) 
 
Based on Eq.7 a 0.05 M solution of a zinc salt in water has a pH of 5.18.  The higher the zinc salt 
concentration the lower is the pH value.  This pH value refers to solution of a zinc salt with an 
undefined anion.  In practice, the pH of solutions of zinc salts depends not only on 
concentrations but also on the chemical composition of the salt.  Solutions of zinc salts therefore 
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can be acidic, neutral or even slightly basic with pH = 7 (neutral) as the relative reference point 
on the acid-base scale.  For example, the pH values of 1–10% (w/w) ZnSO4⋅7H2O (0.035 – 0.35 
M) or ZnCl2 (0.074 – 0.74 M) solutions are between 4.4 and 5.9 depending on the commercial 
source of the salt.  These pH values are in good agreement with calculations obtained from Eq.7.  
However, the pH values of 1-10% Zn(OAc)2 (0.05 – 0.55 M) solutions are between 6.0 and 8.0, 
which is significantly different from those of the above mentioned salts.  The origin of the 
difference in pH values are the acid-base properties of the anion.  Because sulfate and chloride 
are anions of strong acids, they are extremely weak bases and do not affect the pH of the aqueous 
solution.  The reason for the different behavior observed for zinc acetate, citrate, or formate 
solutions is that these anions have basic character and hence oppose the effects one pH due to 
[Zn(H2O)6]2+ hydrolysis.  Acetate reacts with water according to Eq.8 and decreases the pH. 
 
(Eq.8)                                    CH3COO- + H2O    CH3COOH + OH- 
 
The pKb (= pKw - pKa) value of the acetate/acetic acid pair is 9.2 and similar to the pKa1 of 
[Zn(H2O)6]2+ (Eq.6).  Because these opposing effects cancel each other, the pH values of 
Zn(OAc)2·nH2O solutions are neutral despite the fact that cation and anion have acid-base 
properties.  For practical purposes, it is important to note that the pH value of zinc salts varies 
slightly depending on manufacturers and impurities, the carbon dioxide concentration, and the 
time of storage.  It is also useful to remember that zinc salts with anions of strong acids have low 
pH-buffering capacity.  Therefore, addition of a pH buffer at physiological pH to a solution of 
ZnCl2 will immediately change the pH of the solution, possibly resulting in the precipitation of 
zinc hydroxide.  On the other hand, a Zn(OAc)2 solution is a better pH-buffer.  Its pH-buffering 
capacity depends on its concentration and therefore preparation of too concentrated solutions 
also may result in a pH that causes precipitation of zinc hydroxide.  In summary, zinc salt 
solutions in biological buffers without capacity for zinc complexation may provide a rather 
poorly controlled source of zinc ions for biological experiments. 
  Amphoteric characteristics of zinc aquo complexes are evident from further 
deprotonation of water molecules and formation of hydroxo species.  The octahedral zinc 
hexaaquo complex [Zn(H2O)6]2+ is in equilibrium with tetrahedral [Zn(H2O)4]2+ with an 
equilibrium constant much in favor of the former.  For simplicity, the equilibria of aquo 
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complexes with various geometry, [Zn(H2O)x]2+ will refer to either hexaaquo (x = 6) or tetraaquo 
(x = 4) complexes in this article.  Vibrational spectroscopic investigations on aqueous solutions 
of zinc salts demonstrated formation of the tetraaquo complex at high salt concentrations where 
the water content decreases significantly [20].  The zinc pentaaquo-hydroxo complex also is in 
equilibrium with the octahedral and tetrahedral species.  The conversion of [Zn(OH)(H2O)5]+ to 
[Zn(OH)(H2O)3]+ has not been described in detail in terms of its equilibrium constant/energetics.    
The dissociation of another water molecule results in the formation of a neutral [Zn(OH)2(H2O)x-
2](aq) species.  The octahedral species [Zn(OH)2(H2O)4](aq) is less favored due to additional charge 
compensation and stronger repulsion of negatively charged ligands, all of which favor the 
tetrahedral [Zn(OH)2(H2O)2](aq) species.  Ab initio calculations show that the pKa value for the 
dissociation of a proton from a water molecule bound to an octahedral zinc complex is about 0.8 
logarithmic units higher compared to that from a water molecule bound to a tetrahedral zinc 
complex [21].  This phenomenon is important for enzyme catalysis, where a tetrahedral zinc(II) 
provides a significant advantage in terms of providing a higher fraction of the hydroxo species as 
a nucleophile at physiological pH.  The chemistry of aquo and aquo-hydroxo species of zinc is 
quite different from calcium and in addition to function in proteins may be important in 
biological recognition of zinc. Macromolecules sometimes select a minor species from an 
assembly of species as a ligand or substrate. 
Due to our limited knowledge regarding equilibria between octahedral and tetrahedral 
zinc aquo-hydroxo complexes, these complexes are frequently presented in a simplified way as 
Zn(OH)+, Zn(OH)2(aq), Zn(OH)3- and Zn(OH)42- which is a simplification focusing only on the 
number of hydroxo ligands.  The stepwise proton dissociation constants of the second (pKa2 = 
9.75), third (pKa3 = 10.1) and fourth (pKa4 = 10.5) water molecule bound to the central zinc ion 
are average values of the dissociation constants of both octahedral and tetrahedral species, the 
molar fraction of which changes with pH [19].  Eqs.9-11 present stepwise dissociations of all 
zinc aquo-hydroxo complexes.  The final product, the [Zn(OH)4]2- complex (zincate), is 
tetrahedral and has no covalently bound water molecules because of its high negative charge.  
This charge effect forces octahedral complexes present at acidic and neutral pH into a tetrahedral 
complexes at alkaline pH.  
 
(Eq.9)    [Zn(OH)(H2O)x-1]+  + H2O     [Zn(OH)2(H2O)x-2](aq) + H3O+ 
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(Eq.10)  [Zn(OH)2(H2O)x-2](aq) + H2O    [Zn(OH)3(H2O)x-3]- + H3O+  
(Eq.11)  [Zn(OH)3(H2O)x-3]-  + H2O    [Zn(OH)4]2- + H3O+    
Where x = 4 or 6 depending on complex geometry. 
 
The pH dependence of the aquo-hydroxo complexes is based on these equilibria (Figure 2).  The 
deprotonation of coordinated water molecules begins at slightly alkaline pH, above 7.8 (5% of 
[Zn(OH)(H2O)x-1]+), and terminates with the fully deprotonated species above pH 11.8 (95% of 
[Zn(OH)4]2-).  The concentration of the uncharged complex, [Zn(OH)2(H2O)x-2](aq), is highest at 
pH 9.9 and decreases above that value.   
Solid ZnO is formed by calcination (heating at high temperatures) from Zn(OH)2(s) and 
widely used in nutritional and some research applications.
 
 A discussion of the properties of 
Zn(OH)2(s) and ZnO illustrates the issues associated with the dissolution of different forms of 
these compounds and hence availability of zinc for biological systems.  Precipitation of solid 
zinc hydroxide Zn(OH)2(s) observed in mildly alkaline aqueous solutions is strictly related to the 
presence of the uncharged, but water soluble [Zn(OH)2(H2O)x-2](aq) species.  Transition from the 
soluble to the insoluble form requires the dissociation of water.  The type of Zn(OH)2(s) crystals 
formed depend on the total zinc concentration, pH, and temperature.  Six forms of Zn(OH)2(s) 
have been described so far, and they are known as α (amorphous) and crystalline β1, β2, γ, δ and 
ε.  They have widely variable solubility in water according to the series: amorphous > β1 ~ γ > β2 
> ε [22].  Another confounding variable in the determination of the solubility is the use of ZnO.  
In this case, the solubility and thermodynamic equilibration of hydroxo complexes is influenced 
by the slow hydration kinetics of ZnO to yield Zn(OH)2(s) and soluble species of the type 
[Zn(OH)2(H2O)x-2](aq).  Furthermore, ε-Zn(OH)2(s) is unstable with respect to ZnO(s) and H2O and 
also with respect to amorphous Zn(OH)2(s), and the conversion between the various forms of 
Zn(OH)2(s) and ZnO is often slow [22].  ZnO has lower solubility compared to the amorphous 
form of Zn(OH)2(s) (one order of magnitude difference in KSO).  Clear differences in the kinetics 
of transition between ZnO and different forms of Zn(OH)2 and in their solubilities are the reason 
why different procedures result in the production of different forms of ZnO.  
Best characterized is the solubility of the orthorhombic form ε-Zn(OH)2(s) with a KSO of 
3.39 × 10-17 (pKSO = 16.47) at 25 oC and I = 0.2 M  [22].  Based on the solubility product (KSO = 
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[Zn2+(aq)] [OH-]2) and the ionic product of water Kw one can readily calculate the free zinc ion 
concentration or the pH of a solution of ε-Zn(OH)2 according to Eq.12. 
 
(Eq.12)     [Zn2+(aq)] = 'SO[OH-]2 = 
'SO	[*]+
',			+  
 
When calculating the solubility of pH-sensitive solids such as Zn(OH)2(s), it is important to 
include the effect of hydroxo complex formation as a factor that increases the total solubility of 
Zn(OH)2(s) (Figure 2).  Thus, solubility (S) is the sum of all the soluble species discussed above 
at a particular pH value (Eq.13). 
 
(Eq.13) S = [Zn(H2O)x]2+ + [Zn(OH)(H2O)x-1]+ + [Zn(OH)2(H2O)x-2](aq) + [Zn(OH)3-
(H2O)x-3]- + [Zn(OH)4]2- , where x = 4 or 6 
 
Concentrations of a particular species can be calculated based on the individual dissociation 
constants for each step.  However cumulative formation constants (β1-4) are much more 
convenient in practice in order to simplify the computation.  According to this notation β1 (K1), 
β2 (K1×K2) … are [Zn(OH)+]/[Zn2+][OH-], [Zn(OH)2(aq)]/[Zn2+][OH-]2 … and their logarithmic 
values are 4.95 (β1), 9.20 (β2), 13.1 (β3) and 16.6 (β4).  Since the effect of different numbers of 
coordinated water molecules on these constants is not known, water molecules are omitted here 
for clarity.  When combining Eq.13 with the concentrations of particular zinc species, the 
solubility of Zn(OH)2(s) is expressed by Eq.14.  Combining the solubility and solubility constants 
(KSO) allows for calculation of the total concentrations (sum of all Zn(II) forms, Zn2+(aq)) of 
soluble species at any given pH (Eq.15). 
 
(Eq.14)    S = [Zn2+(aq)] (1 + β1[OH-] + β2[OH-]2 + β3[OH-]3 + β4[OH-]4 
 
(Eq.15)   S = KSO - [OH-]2 +	
./
[OH-] +	01 +	0 2OH-3 + 	04[OH-]25 
 
Eq.15 also allows for calculating the solubility of Zn(OH)2(s), which is frequently considered as a 
completely insoluble zinc species.  In a presentation of the relationship between pH and the 
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solubility of zinc hydroxide (Figure 3), the ordinate gives the sum of all soluble zinc species 
[Zn2+(aq)] present at various molar fractions at a particular pH.  For example, -log values of the 
concentration of all soluble Zn(II) species at pH 7 and 7.4 are 2.47 and 3.26, corresponding to 
3.4 and 0.55 mM, respectively.  Even at pH ~ 10, where the solubility of Zn(OH)2(s) is lowest, 
the concentration of soluble zinc species is 0.13 µM.  These values are much higher than what 
researchers usually estimate.  They have been confirmed experimentally, for example by using 
atomic absorption spectrophotometry [23].  A relatively high solubility of Zn(OH)2(s) is the 
reason why addition of ZnSO4 or ZnCl2 at submillimolar or millimolar concentrations to a 
HEPES buffer (at a pH close to the pKa of the buffer) does not result in precipitation.  This fact 
turns out to be useful when preparing solutions of these zinc salts for biophysical measurements 
[24]. 
Another important issue in zinc hydroxo complex chemistry is olation, the formation of 
polynuclear species, such as [Zn2(OH)6]2- and complexes of higher nuclearity.  Polynuclear 
complexes are formed rather slowly and many of them are kinetic intermediates in the slow 
transition from soluble hydroxo mononuclear complexes to a solid precipitate and are thus 
thermodynamically unstable.  The formation of precipitates may be observed when storing stock 
solutions of zinc salts.  Their “aging” has many reasons, such as formation of carbonates or 
mixed complexes, presence of impurities, and it may also involve the formation of polynuclear 
species, which are less soluble in water.  Upon dilution, the fraction of polynuclear zinc hydroxo 
complexes in aqueous solutions decreases.  
While this presentation of the chemistry of zinc aquo complexes may seem quite 
involved, nevertheless it is fundamental to zinc in biology and to the preparation of various 
solutions of zinc salts and complexes for controlled and well-designed experiments in the 
laboratory and for the feeding of organisms.   
Zinc aquo complexes have to exchange their water molecules when binding to other 
ligands.  Binding to any protein site requires such ligand exchange.  It is particularly relevant 
when zinc is transported as transport involes multiple ligand exchanges.  The 3D structure of the 
bacterial zinc transporter E. coli YiiP, which belongs to the family of cation diffusion facilitators 
(CDF), shows that the transported species apparently is a Zn2+ ion without bound water 
molecules or LMW ligands when it is bound in the primary site to one histidine and three 
aspartate side chains [25].  If a zinc ion without ligands in transfer or transport in a protein exists 
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transiently, we suggest referring to it as a “naked” zinc ion to distinguish it from the “free” zinc 
ions with bound ligands in solution.  The energetics of ligand exchange therefore are critical to 
the functioning of this and other zinc transporters.  The properties of the Zn-O bond in zinc 
bound-water molecules are at the center of mechanisms of zinc metalloenzymes, in particular the 
modulation of the pKa of the Zn2+−OH2 to Zn2+−OH- transition, which provides the nucleophile 
for hydrolytic reactions.     
Deprotonation of zinc aquo complexes leads to species with different charges and they 
are important for interaction with proteins.  The pH dependent species of zinc aquo complexes 
are also important when performing experiments with zinc compounds.  The acid-base properties 
need to be considered when making stock solutions of zinc salts or zinc complexes.  The type of 
salt and its concentrations are important with regard to whether or not enough pH buffering 
capacity is available to keep zinc ions in solution.  Stock solutions of zinc salts in water or buffer 
are often added to culture media for cells or bacteria and the solubility as the well as the possible 
complexation by pH buffers and other components of the media must be considered and 
understood.   
Zinc compounds are used in nutritional studies of organisms.  ZnO, for example, has 
been used in the large age-related eye disease study (AREDS) [26].  When using this compound, 
it is important to know the chemical properties of the different commercially available products 
in the corresponding biological environment in order to understand bioavailability.  The physical 
properties, such as solubility and particle size, can vary significantly for ZnO from different 
suppliers.  This variation also applies to manufactured ZnO nanoparticles, which are now being 
increasingly employed in feeding and investigated with regard to their effects on biological 
systems.   
One issue not addressed above is that a precipitate can be formed when dissolving ZnCl2 
in water.  Despite the high solubility of the salt, the precipitate is due to the formation of zinc 
oxychlorides, of which at least 16 different forms have been described [27].  One important form 
is tetrabasic zinc chloride (TBZC), zinc chloride hydroxide monohydrate with the chemical 
formula Zn5(OH)8Cl2⋅H2O [28].  It has a variety of application in animal feed, as a fungicidal 
additive to plant food and in medicine/dentistry. 
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3.2. Biologically important anions 
In natural waters, zinc speciation has been investigated widely and Zn2+(aq), ZnCO3o, ZnSO4o, 
Zn(OH)2o, ZnCl+, ZnCl2, ZnCl3-, and Zn(Cl)42- have been identified [29].  In this literature, the 
supscript (o) refers to the soluble forms, ie. Zn(OH)2o = Zn(OH)2(aq).  The chemical formulae do 
not indicate the bound water molecules.  Thus, ZnCl+ is actually [ZnCl(H2O)x-1]+ according to 
the speciation and nomenclature discussed above.  The concentrations of these species depend on 
the pH of the aqueous solution, the anion concentrations and the presence of dissolved organic 
matter (DOM), which on average contributes with a logK of 6.4-7.0 with ligands such as humic 
and fulvic acid.  Chloride species become important with increasing salinity.  The concentrations 
of zinc hydroxo and carbonato complexes increase above pH 7.5 and become the predominant 
species above pH 8.  Sulfide also contributes, even in oxic water.  In anoxic water, ZnS 
nanoparticles and Zn-S clusters have been identified: [Zn3S3(H2O)6] and [Zn4S6(H2O)4]4- [30, 
31].  It is quite remarkable that the nuclearity of these complexes with regard to zinc is exactly 
what is found in the two zinc-sulfur clusters of mammalian metallothioneins.     
Distribution of elements in blood often reflects their distribution in sea water.  However, 
within cells, a different milieu is maintained as the concentrations of chloride and hydrogen 
sulfide (HS-) are kept relatively low, though the latter is a signalling substance and a component 
of the structure of Fe-S clusters.  Whether these anions (Table 1) are involved in coordinating 
zinc ions or the presumable coordination changes during zinc transport from/into cells is not 
known.  In the cell, these anions are also buffered, ie. there is a controlled equilibrium between 
free and bound, though the term buffering is not used in this context.  Hydrogen sulfide is kept at 
very low concentrations, but hydrogen phosphate (HPO42-), sulfate (SO42-), hydrogen 
carbonate/carbonate (HCO3-), and chloride are all present at millimolar concentrations (Table 1).  
Hydrogen sulfide, hydrogen phosphate, and sulfate are the strongest inorganic anions for zinc 
(Figure 4).  There is also diphosphate (pyrophosphate, P2O74-), triphosphate (P3O105-), 
tetraphosphate (P4O136-), and inositol phosphate (section 4, Table 2), all of which bind zinc much 
more efficiently with apparent dissociation constants (pKd) of 2.7, 6.9, 7.2 and 10.4, respectively. 
[32-35].  Acetate, carbonate, and chloride are ligands with intermediate strength for coordinating 
with zinc ions, and some anions are biological ligands of zinc in proteins.  Free acetate is 
expected to be very low as it is mainly in the form of acetyl-CoA.  Other organic acids that are 
metabolites can also serve as potential ligands (Table 2).  Hydrogen carbonate is a ligand in the 
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zinc enzyme carbonic anhydrase.  Chloride has been identified as a ligand of zinc in the crystal 
structures of some zinc proteins.  Chloride is likely to be a ligand in ternary complexes with 
other ligands if expansion of the coordination sphere is possible.  Hydrogen phosphate interacts 
with zinc sites in metallophosphatases.  Chloride complexes are likely significant in the stomach, 
which contains up to 0.1 M HCl, whereas carbonate complexes likely play a role in the 
duodenum where Brunner’s glands provide an alkaline secretion high in bicarbonate to neutralize 
the acid from the stomach.   
When preparing zinc salt solutions for biological experiments the possibility of these 
anions forming zinc complexes and affecting the outcome of the experiment(s) is significant and 
should be considered, in particular in the absence of other ligands with competing affinity for 
zinc.  Physiological salt solutions are often based on phosphates and so are cell culture media, 
which provide ligands for zinc in the absence of serum.  Considering speciation of complexes 
with anions is not only important for bioavailability of zinc ions but also for interactions with 
proteins, which may be very specific and lead to either activation or inactivation of a biological 
process.  Sodium or potassium chloride added to biological buffers to adjust their ionic strength 
will change zinc speciation, especially in the absence of other ligands with high affinity for zinc.  
Perchlorate does not occur in biological systems and nitrate concentrations are very low (Table 
1).  Other negatively charged metal anion or oxoanion complexes may also form insoluble zinc 
complexes.  Examples are [Fe(CN)6]4- or [Hg(SCN)4]2- used in analytical chemistry to precipitate 
zinc ions. 
 
4. The complexation of zinc with ligands other than water and the stability of zinc 
complexes  
All biologically important molecules such as amino acids, peptides, proteins, carbohydrates, 
nucleotides, DNA and RNA, and vitamins contain atoms that can serve as electron pair donors 
for metal coordination and therefore can be considered as potential ligands for metal ion binding 
[36].  However, many interactions may not be strong enough to be physiologically significant.  
Accordingly, the biological zinc chemistry has focused almost exclusively on proteins.  
Ligands are called monodentate if they possess only one donor atom or donate just one of 
their available pairs of electrons to the metal ion.  They are called multidentate if they possess 
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more than two donor atoms.  Multidentate ligands can form chelates, ring structures of 
covalently linked donors around the central metal ion.  The highest stability is attained when 5- 
or 6-membered chelate rings are formed.  The prototype of a ligand that forms a 5-membered 
chelate ring and occupies six coordination positions around the zinc ion is 
ethylendiaminetetraacetic acid (EDTA).  The chelate effect makes an important contribution to 
enhancing the stability of low molecular weight zinc complexes when compared to monodendate 
complexes as it increases the entropy of the system [37]. 
How stable zinc complexes are is determined by the (Gibbs) free energy, which has an 
enthalpic and an entropic contribution.  Changes of either one affect complex stability (Eqs.16 
and 17). 
 
(Eq.16)    ∆G° = -RT lnK = ∆H° - T∆S°;  
(Eq.17)     lnK = ∆H°-	T∆S°-RT  
 
The enthalpic contribution to complex stabilization derives from the metal ion preference for 
particular donors.  Such a preference was described early on in a concept that grouped metal ions 
into two categories, A and B [38].  The grouping depends on whether the complex is more stable 
with a donor atom from a member of the first periodic group (F, O, N) or with a member of a 
subsequent group (Cl, S, P).  In this classification, Zn(II) belongs into category B, in which 
neither the charge nor the size of the interacting atoms/ions is the primary reason for the stability.  
Stability of the complex increases with the ionization potential of the metal (charge density) and 
with decreasing electronegativity of the ligand donors, ie. the tendency of a ligand to donate 
electrons.  In the series F, O, N, Cl, Br, I, and S, the electronegativity decreases from left to right 
while the stability of the complexes with zinc increases.  In another concept, metal ions and 
ligands are grouped into soft and hard acids and bases (SHAB) depending on the degree of their 
polarizability [39].  In this classification, Zn(II) belongs to a borderline category of acids with a 
tendency to form stable complexes with moderately polarizable ligands (bases) such as nitrogen 
donors.  The borderline character of Zn(II) is also seen in its tendency to form complexes with 
both hard oxygen and soft sulfur donors in biological complexes with low molecular weight 
(LMW) or high molecular weight (HMW) ligands.  Zinc forms stable octahedral complexes with 
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L-histidine and citrate with oxygen and nitrogen donors [40, 41] as well as interacts with up to 
four sulfur donors from cysteine residues in tetrahedral zinc-thiolate sites in proteins, where 
binding may also include nitrogen donors from histidine residues [6, 42].  Enthalpic effects on 
complex stability are frequently hidden deep in the protein structure.  Additional interactions 
such as hydrogen bonding and electrostatic interactions within the ligand formed during the 
complexation also affect the stability significantly [3, 5, 24, 43].   
The entropic contribution to complex stabilization derives mostly from the chelate effect 
mentioned above and the structure of the protein or LMW ligand when it changes during 
complexation.  The chelate effect is particularly prominent in proteins when the zinc binding site 
is not preformed.  It can be readily seen in the complexation of zinc with EDTA when six water 
molecules are replaced by one ligand molecule of EDTA (Eq.18).  
 
(Eq.18)  [Zn(H2O)6]2+ + EDTA2-    ZnEDTA2- + 4H2O + 2H3O+ 
 
The increase in the number of ligands (products) provides an entropic driving force for the 
reaction.  The increased entropy is associated with higher complex stabilization (Eq.17).  Aside 
from this chelate effect referring the formation of a ring structure, stability of zinc complexes can 
increase by a macrochelate effect, which refers to entropic effects in the outer coordination 
sphere, which is common in proteins. 
Important issues for complex formation are the charge of the ligand and its acid-base 
properties.  Most of the biological ligands possess acid-base properties and their complexation is 
linked to the loss of proton(s) (Eqs.19-21). 
 
Eq.19     RSH + Mn+    RS-M(n-1)+ + H+ 
Eq.20     RNH3+ + Mn+    RNH2-Mn+ + H+ 
Eq.21    R(COOH)NH3+ + Mn+    R(COO)NH2-M(n-1)+ + 2H+ 
 
The strength of competition between metal ions and protons is strictly related to the complex 
stability and the acid-base properties of the ligand.  In general, stabilities of complexes are higher 
at higher pH because the competition between metal ions and protons decreases.  The association 
or formation constant (K or Ka, unit M-1) or the dissociation constant (Kd, unit M) describe the 
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stability of the complex at particular conditions (temperature and ionic strength, I).  If the 
constants describe the same equilibrium their values are reciprocals: Ka = 1/Kd.  If complexation 
is associated with the dissociation of protons, calculation of Ka or Kd requires knowledge of the 
acid dissociation constants of the ligand donors.  
Most of the biologically important metal complexation equilibria occur at a constant pH 
value, ie. they are pH-buffered.  In this case, the association constant is defined in a much 
simpler way (Eqs.22 and 23).  In order to differentiate between values that refer to unbuffered 
and buffered conditions the latter values are called apparent (Kapp or conditional constants 
referring only to a particular pH value).  Determination of apparent constants does not require 
knowledge of the acid-base properties of the ligand (L), which is a convenient way of describing 
binding properties of macromolecules.  
 
Eq.22     Lx + Mn+    MLx+n 
Eq.23       :: = [;<]
=*>
[<]=[?]>* 
 
With the known values of the pH-dependent association constant and the acid dissociation 
constants one can calculate the apparent constant at any pH value.  This conversion is very 
important in biology.  For example, for the formation of the Zn-EDTA complex (Ka = 16.46), 
one calculates Kaapp = 13.22 and 13.64 at pH 7.0 and 7.4, respectively (Figure 5a) [44].  Ionic 
strength and temperature also have a significant influence on the stability of the complex (Figure 
5b,c).  The conversion of Ka to Kaapp is important when using tabulated data of Ka, for example 
for zinc chelators (Table 3).  Their binding constants need to be converted to the proper 
conditions of the experiment (pH, ionic strength and temperature). 
In order to determine apparent stability constants of the agents that potentially interact 
with Zn2+ one needs a readout such as a change of absorbance, fluorescence, ellipticity etc. upon 
Zn(II) binding.  The constants can be determined in direct titrations experiments if the affinity of 
Zn2+ towards the molecule of interest is not lower than ~10-8 M.  This value depends on the 
physicochemical property investigated under Zn2+ binding and the ratio between the maximal 
and minimal value of the measured parameter, i.e. the sensitivity, and the concentrations of 
reactants.  Indirect determinations can be performed in zinc-buffered media.  In both 
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applications, knowledge about the stoichiometry of the interaction is required as it affects the 
numeric value and unit of the constant.  Such information can be obtained by Job’s method of 
continuous variation [45].  Metal buffers are solutions of chelating agents with various amounts 
of total zinc and they are chosen for buffering in certain pZn ranges (Table 3).  Ideally they form 
1:1 complexes.  Control of pZn values from the low attomolar range in the case of TPEN to 
micromolar in case of IDA is possible.  The values of pZn are calculated by Eq. 3 and depend on 
pH, temperature and ionic strength.  The calculation can be performed using any of the available 
programs, such as the simplest, MaxChelator, or more advanced ones such as MINEQL+ and 
Hyperquad Simulation and Speciation software [46-49].  All mentioned programs contain sets of 
stability data for various metal ions under various conditions.  The more advanced software 
allows for developing models based on a particular chelator or the stability determined at various 
conditions.  The most common format available in those software packages are conditional (not 
apparent) pH-independent constants that are tabulated from several databases such as those from 
IUPAC, NIST, or the Martell and Smith compendium [44].  Results are usually presented as pZn 
as a function of the investigated physical parameter and are fitted to single or multiple binding 
models using software such as Origin (OriginLab Corporation), SigmaPlot (Systat Software 
Corporation), DynaFit (BioKin Ltd).  Frequently, data are fitted to Hill’s equation that allows for 
evaluation of whether or not the process involves cooperativity in binding [50].  Two conditions 
must be fulfilled: the reactions need to reach equilibrium and the interference of the metal buffer 
with the reaction must be negligible.  If it is not negligible calculation must include the 
distribution between the metal buffer and the ligand under investigation. 
 Calculations with stability constants become more complex for stoichiometries other than 
1:1 between metal ion and ligand.  For instance, most amino acids form ZnL, ZnL2, or even ZnL3 
with zinc ions.  Formation of each complex is defined by a separate equilibrium, leading 
stepwise to the complexes, ie. ZnL2 is formed by association of a ligand molecule to the ZnL 
species (K2) and ZnL3 is formed from ZnL2 (K3).  The formation of ZnL2 also can be described 
by the cumulative formation constant β(ZnL2) which is K1×K2.  Frequently, β values are given as 
association and dissociation constants but then their units differ from those of M-1 and M.  Thus, 
dissociation of the ZnL2 complex to Zn2+ and two molecules of L has the unit M2.  The pH-
dependent, stepwise or cumulative association constants also require knowledge of the acid-base 
properties of the ligand in order to calculate the apparent values of ZnL, ZnL2 and ZnL3 
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complexes (K1app, K2app, K3app or β(ZnL)app, β(ZnL2)app and β(ZnL3)app).  All these equilibria, 
which differ for ligands, cause a significant problem for comparison of zinc affinities of ligands 
that form complexes with various stoichiometries.  A straightforward comparison of binding 
ability can be performed only for apparent constants of complexes with the same stoichiometry.  
In order to be able to compare complexes with different stoichiometries, the concept of a 
competitivity index has been introduced [40].  Accordingly, all zinc complexes at particular 
conditions with various stoichiometries and protonation states are summed up and treated as a 
complex of a virtual molecule Z (Eq.24).  The Competitivity Index (CI) is then the dissociation 
constant value of the MZ species defined by the Eq. 25. 
 
Eq.24     [MZ] = Σijk[MiHjLk] 
Eq.25         CI = [?][@][?@]  
 
This concept, with all its limitations, allows comparison of simple ligands with much more 
complicated ones in terms of their protonation and stoichiometry at a particular pH value. CI 
indices are included in Table 2 and provide a convenient means of comparing zinc binding 
ability of the number of pH buffer components, disulfide reductants, carboxylic acids, amino 
acids, nucleotides, natural redox buffers, antibiotics, etc. 
The pH dependence of complexation has important implications for biology because 
there are significant differences of pH values in different organs and even in different cellular 
compartment.sIncreasing the pH value causes deprotonation of a ligand with acid-base properties 
and complexation while decreasing the pH has the opposite effect.  The acid-base properties of 
the ligand change with complexation: strong binding perturbs the pKa considerably while weaker 
binding has a smaller influence on the pKa value of the ligand.   
 
5. The coordination of zinc in the “free” zinc pool 
While the first part of this article addressed the chemical principles of zinc coordination (water, 
anions, and other ligands) as relevant for biology, the second part amplifies the subject of 
biological significance, in particular (i) the speciation of zinc ions in vivo and the few instances 
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where LMW ligands interacting with zinc have been identified for specific functions and (ii) the 
coordination chemistry of the LMW “tools” employed for investigating zinc ions in biology.     
Ligands of the pool of cellular “free” zinc ions (not protein-bound) and the ligands of 
zinc ions during transport or transfer are generally not considered and knowledge is very limited 
though some investigations indicate a role of specific complexes.  It is a fundamentally important 
issue which zinc species proteins recognize, and it may be a key to specificity, but a lack of 
methods to investigate speciation at the very low concentrations of zinc ions has precluded 
progress.  However, there are at least two reports where extracellular interactions of specific 
species of zinc with proteins have been investigated.  For example, it has been demonstrated that 
a particular species of zinc(II) is involved in metal association with a protein.  The species 
Zn(His)+ was found to be the preferred substrate for membrane transport, suggesting a role of 
amino acids in biological zinc complexation [51].  Histidine forms 1:1 and 2:1 complexes with 
zinc (Table 2, Figure 6).  The 2:1 complex Zn(His)2 has no overall charge.  The species relevant 
for inhibition of carboxypeptidase A was identified as Zn(OH)+ [19].  In importance of zinc 
speciation and overall charge of the zinc complex has been demonstrated by an investigation into 
the efficacy of zinc lozenges to treat the common cold.  Neutral zinc complexes had no effect, 
negatively charged zinc complexes worsened the outcome, and only positively charged zinc 
complexes were efficacious [52].  It has been discussed that the rates of zinc transfer would be 
low on a biologically meaningful time scale at the very low concentrations of zinc ions 
prevailing in the cytosol.  For instance, if concentrations were as low as 1 pM, zinc dissociation 
rates would be in the order of 14 h, assuming diffusion-controlled association rates [53].  At least 
two pathways are envisioned to overcome this dilemma.  One is direct associative transfer 
between proteinsas has been observed for transfer of zinc between metallothioneins and for 
transfer or other metal ions by metallochaperones, and the other is a role of LMW compounds in 
“catalyzing” zinc transfer.  Such an enhancement of zinc transfer has been observed in model 
reactions where compounds that have affinities between those of the zinc donor and the zinc 
acceptor facilitate metal transfer [54, 55].  Evidence for such reactions being biologically 
relevant came from the observation that carbonic anhydrase, which exchanges zinc very slowly 
(t1/2 > 100 days), equilibrates rapidly in the cell [56].   
Glutathione, ATP, citrate, and amino acids are all candidates for chelating ligands in the 
LMW pool of zinc (Figure 6).   Evidence for involvement of ATP as a ligand of zinc has been 
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provided, thus demonstrating in principle how biological specificity by LMW species can be 
achieved.  Some kinases phosphorylating vitamins prefer a ZnATP complex over a MgATP 
complex [57].  In the crystal structures of flavokinase and pyridoxal kinase a bound ZnATP 
complex was detected [58, 59].  ATP forms a rather stable complex with zinc because the N7 of 
the adenine moiety provides an additional ligand (Kd and CI value of the ZnL complex is 7.68 × 
10-6 M; Table 2, Figure 6) [60, 61]. 
Glutathione (GSH) as a ligand is particularly intriguing for conferring specificity in metal 
transfer reactions as zinc forms a variety of complexes with GSH (Kd of 8.74 × 10-9 M2 for ZnL2 
complex corresponding to a -logCI value of 5.27, Table 2, Figure 6) as a function of pH and 
GSH concentrations, including ternary complexes [40, 62, 63].  GSH has been discussed as a 
ligand of the LMW Fe(II) pool [64].   
Further exploration of whether or not complexation or changes in complexation of zinc 
ions determines specificity in biological processes is an important issue for understanding how 
zinc is provided to proteins for binding, how cellular sensors and transporters recognize zinc, and 
for how and where zinc expresses its function as a signalling ion at target sites in proteins [65].  
In the absence of knowledge of the coordination of zinc in the LMW zinc pool, virtually all 
experiments employ zinc salts in biological buffers without recognizing that the species of zinc 
in such solutions most likely are not the biological substrates.   
One important aspect of the homeostatic control and re-distribution of zinc in humans is 
its storage in cellular vesicles, which are solute compartments with properties different from the 
cytosol.  In most instances, it is not known in which chemical form zinc is stored in intracellular 
vesicles, and how its coordination changes once it is released from the vesicles.  Vesicular 
exocytosis releases zinc into the extracellular fluid, and brings zinc a biological compartment 
that provides different coordination environments.  In zinc-rich neurons in the brain, zinc is co-
released with glutamate from vesicles that are loaded with zinc by the transporter ZnT3.  
Whether zinc forms a complex with glutamate in the vesicles is not known.  The Kdapp of the 
ZnL2 complex with glutamate is 2.2 × 10-6 M2, with a -logCI value of 2.7 corresponding to the 
strength of the interaction of zinc with HPO42- (Table 2) [66].  Preliminary investigations of zinc-
rich vesicles by extended X-ray absorption fine structure (EXAFS) spectroscopy demonstrated 
O, N, and S-coordination [67].  Presumably, at the lower pH value in the vesicles zinc ions are 
more weakly bound.  Upon exocytosis zinc is released into the synaptic cleft, which has a higher 
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pH, and thus it is expected to be bound more tightly.  In the endocrine pancreas, zinc is 
transported into insulin-containing secretory granules of β-cells by the transporter ZnT8, where it 
has a role in storing crystalline insulin as a hexamer with two bound zinc ions.  The coordination 
environment of zinc depends on whether the hexamer is in the R or in the T state.  Zinc is co-
secreted with insulin (and amylin), and monomeric insulin coordinates zinc with a Kd of 0.4 µM 
[68].  In the exocrine pancreas and in epithelia of mammary glands, the transporter Zn 2 loads 
the vesicles with zinc.  In the exocrine pancreas, zinc it thought to have a role in inhibiting 
proteases stored in these vesicles.  In the mammary glands, vesicular zinc is exocytosed into the 
milk.  In addition to being bound to proteins, zinc is bound in a LMW pool in milk, which has 
been identified as a zinc-citrate complex in humans [69, 70].  Zinc ions form ZnL and ZnL2 
complexes with citrate with different overall charges.  The 2:1 is favored because its Kd is 1.17 × 
10-12 M2 corresponding to a -logCI value of 8.93 (Table 2, Figure 6) [41].  Micromolar 
concentrations of picolinate were also found in human milk and a zinc-picolinate complex was 
isolated [71].  The prostate is another organ where zinc is secreted from vesicles into the prostate 
fluid.  In the prostate, zinc inhibition of aconitase is thought to be responsible for the 
accumulation of citrate, which could serve as a zinc ligand in prostatic secretion and in seminal 
fluid [72].  The coordination environment of zinc in other zinc-storing vesicles and its change 
when secreted from a variety of other zinc-secreting cells is not known, nor is it known in which 
form cytosolic zinc is provided to the ZnT transporters.  The LMW ligands of zinc in urine, 
blood or other biological fluids have not been identified.   
It is not known to which extent LMW ligands participate in zinc buffering, whether zinc 
buffering occurs exclusively by proteins, LMW complexes, or a combination of both, and  to 
which extent the buffering capacity changes and the pZn differs in different cell types.   
Bacillithiol has been identified as an important component of zinc buffering in some 
bacteria [73].  It forms a ZnL2 complex with an apparent Kd of 5.4 × 10-13 M2 (-logCI = 9.27).  
Like glutathione it is a redox active component of the LMW zinc pool, linking the availability of 
zinc from this pool to the redox state of the cell.  Thus, not only is the protein pool with zinc 
coordination to sulfur redox-sensitive, but also the LMW pool. 
There is evidence for the participation of metallochaperones and metallophores in the 
acquisition and redistribution of zinc.  The nomenclature is not consistent.  Metallochaperones 
are proteins.  Based on the definition that metallochaperones metallate apoproteins to make 
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metalloproteins metallothioneins classify as zinc chaperones.  However, the term has also been 
used for chemically synthesized LMW compounds that can deliver zinc from the blood to 
cellular proteins owing to (i) affinities between those of blood proteins such as albumin and 
cellular zinc metalloproteins and (ii) being sufficiently hydrophobic to cross biological 
membranes, i.e. they are ionophores [74].  Metallochaperones for zinc have been identified in the 
periplasmic space of bacteria [75].  It is a pressing issue whether or not, and if so under which 
circumstances, metallochaperones for zinc are required in eukaryotes.  Employing zinc 
chaperones may not to be an obligatory process in zinc re-distribution in eukarya as too many 
chaperones would be required to provide specificity for interaction with the about 3000 predicted 
human zinc proteins.     
Zincophores similar to the established siderophores (Fe) and chalcophores (Cu) have 
been described.  Zincophores are different from ionophores that transport zinc through the 
membrane, such as pyrithione which forms a neutral ZnL2 complex (Figure 6) with an apparent 
Kd of 5.0 × 10-12 M2 (-logCI = 8.30, Table 2) [76].  Zincophores are typically found in bacteria 
that need to acquire Zn(II) in an environment with either low zinc concentrations or high 
competition for zinc.  Hence, they need relatively high affinity to scavenge zinc ions.  One 
zincophore is ethylene-N,N′-diaminedisuccinic acid ([S,S]-EDDS) [77], which has a Kd of 2.3 × 
10-11 M (-logCI = 10.6, Table 3).  Its high affinity for zinc is comparable with common chelators 
such as EGTA and HEDTA [44].  Evidence is now accumulating that some siderophores also 
may actually be zincophores [78].  The term zincophore has been employed for the protein Pra1 
secreted from C. albicans and involved in scavenging Zn(II) [79].  Pra1 has orthologues in other 
fungi but not in vertebrates.  The complexation chemistry of zincophores is important because 
they compete with the host for zinc.  Therefore, it may be possible to develop new therapeutic 
agents with antibacterial/antifungal activities.  
It is known in the scientific community but not widely acknowledged for practical 
purposes that several antibiotics bind zinc, e.g. tetracycline and gentamcyin (Table 2).  When 
antibiotics are prescribed to treat infections or given prophylactically, the interaction with zinc 
may be an issue for their efficacy and/or affecting zinc availability and thus the nutritional zinc 
status of the host.  In fact, the importance of this mechanism of action has been demonstrated for 
vancomycin, which restricts the access of bacteria to zinc [80].  
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Nicotianamine, an amino acid derivative and a precursor of siderophores, is involved in 
zinc (and iron) metabolism in plants [81].  Its apparent Kd is 1.6 × 10-11 M (Table 2) [82].  It 
transports zinc from roots to shoots and is also secreted from the roots in metal 
hyperaccumulator plants [83].  In this case, instead of being a chelating agent for uptake of a 
metal, it is secreted to serve as a chelating agent for the excess zinc in order to avoid further 
uptake.  This principle is related to that of other compounds that are antagonists of zinc uptake 
such as phytate (inositol hexaphosphate).  Its Kd is 3.7 × 10-11 M (Table 3) [35]. 
 
6. The coordination chemistry of “zinc tools”  
The “tools” for investigating zinc in biology include at least three types of agents: (i) chelating 
agents to remove zinc ions or buffer zinc in certain ranges of pZn, (ii) pharmacological agents 
such as ionophores to transport zinc through cellular membranes and deliver zinc in a 
bioavailable form, and (iii) chromophoric and fluorescent probes to investigate zinc-dependent 
processes (Table 3). 
The strategy of designing zinc probes is well established and the properties of the probes 
such as sensitivity, selectivity and affinity have been discussed widely [84].  One major principle 
is that a chelating agent is coupled to a fluorophore and once zinc is bound, fluorescence is 
“turned on.” The tools were developed without prior knowledge of the properties of the 
biological pools of zinc and accordingly a lot of discussions ensued which species they actually 
measure.  For example, probes and sensors purported to measure “free” zinc ions can compete 
with protein-bound zinc and/or their response can be modified by binding other ligands [65, 85].  
For future investigations, it is important that knowledge of zinc speciation informs the 
development and application of tools.  
 Two compounds are widely used in zinc biology: 2-mercaptopyridine-N-oxide 
(pyrithione) (Figure 6), which is an ionophore and employed to increase cellular zinc ion 
concentrations, and N,N,N′,N′-tetrakis(2-dipyridylmethyl)ethylenediamine (TPEN), which is a 
membrane-permeable chelating agent that is employed to bind cellular zinc in order to make it 
unavailable for other processes (Kd at pH 7.4 is 6.4 × 10-16 M for the ZnL complex, Table 3) 
[44].  Both agents are used to calibrate cellular zinc probes and sensors by saturating their 
binding sites (with pyrithione) and by removing their zinc (with TPEN).  
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 Chelating agents are also used as zinc buffers in experimental investigations.  Chelating 
agents that can be employed for buffering zinc over a wide range of pZn values (4.2–16.2) are 
available and will be an essential tool for future investigations (Table 3). 
There are two common issues with zinc complexation when using biological buffers.  
One is that many pH buffers serve as ligands of zinc.  Phosphate buffer forms ZnHPO4 (Table 2) 
and then Zn(OH)2(s) or insoluble zinc phosphates depending on the actual pH of the buffer and 
zinc concentrations. Another frequently used buffer, Tris, also forms a weak ZnL complex (Kd = 
33 mM, Table 2).  Many Good’s buffers have nitrogen donors and bind zinc [86].  HEPES has a 
sulfonate group that serves as an oxygen donor.  Glycine binds zinc with millimolar affinity at 
neutral pH and much stronger (micromolar affinity) at pH 9, the region in which it is typically 
employed as a pH buffer (Table 2) [87].  Bis-tris, bis-tris propane, bicine and tricine bind zinc 
much more efficiently than Tris.  The Kd values for bicine and tricine are ~ 10-5 M at pH 7.4 
(Table 2) [88, 89].  Thus in any zinc competition experiment with moderately strong zinc-
binding ligands, the zinc binding capacity of pH buffers needs to be considered.  The second 
issue is the use of reducing agents that are necessary at relatively high concentrations to provide 
a reducing environment similar to the one in cells.  The reducing agent, especially if it is based 
on thiols, may bind zinc tightly and thus remove zinc from the protein.  Also, zinc binding 
changes the redox properties of the reducing agent.  Dithiothreitol (DTT, Cleland’s reagent) is 
widely used for many standard biological buffers.  It forms several complexes with zinc with 
various stoichiometries and with coordination involving its two thiolates. Its affinity towards 
zinc measured by the CI index is nanomolar (-logCI = 8.3, Table 2) [90].  A recently introduced 
reagent dithiobutylamine (DTBA), similar in structure to DTT, binds Zn(II) even more tightly 
with subnanomolar affinity (-logCI = 9.3, Table 2)  [91].  Two other reductants frequently used 
bind zinc less tightly with submillimolar affinity: 2-mercaptoethanol and tris carboxyethyl 
phosphine (TCEP), which has a more negative redox potential [92, 93].  
 
7. Conclusions 
Zinc-ligand bonds involve the spherical 4s electron shell and have about 20% covalent character 
[94].  A consequence is that the zinc ion is stereochemically inactive and quite flexible regarding 
coordination numbers with coordination dynamics that do not underlie the stereochemical 
constraints typical for the transition metal ions.  It is also different from magnesium (Mg2+) and 
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calcium (Ca2+) as it forms much stronger complexes with water and a variety of anions and 
ligands.  These characteristics are important for its biological functions.  The simultaneous 
presence of other metal ions and anions in the biological environment sets constraints on the 
stability of zinc/protein complexes.  Zinc exchange kinetics can be restricted in proteins, but the 
generally fast ligand exchange kinetics endow zinc with characteristics well suited for signalling 
and re-distribution on biological time scales.  The different zinc complexes discussed here are 
important in zinc transfer between the different pools.  Minimally, these pools include equilibria 
between: 
 
Zn2+(aq) or Zn-anion(s)    Zn-LMW chelates (    Zn-Chaperone)    Zn-Protein  
 
Changes in zinc species are important when zinc is transported through membrane proteins.  
Hydration chemistry and the ionization of its bound water are important for its function in 
enzymes (Zn-OH as a nucleophile), where it also forms complexes with anions and chelating 
ligands.  Furthermore, knowledge of zinc species informs the formulation of zinc complexes for 
use in animal feed, where often ZnO is used, for bioavailability when supplemented in the 
human diet [95], when performing experiments with cultured cells to increase cellular zinc, to 
treat a zinc deficiency, or when chelating agents are employed to decrease zinc concentrations.  
Knowledge of zinc chemistry impacts many areas, e.g. nutrition, toxicology, and pharmacology.  
It is anticipated that different zinc species provide biological specificity.  Finally, it is a pressing 
issue to determine zinc species to understand transporter characteristics, zinc sensing, and zinc 
signalling.  In the absence of knowledge about LMW ligands, virtually all experiments are 
performed with zinc salts and thus inappropriate substrates for biological interactions. 
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EDTA – Ethylenedinitrilotetraacetic acid;  
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Figure Legends 
 
Figure 1.  Pourbaix diagram for the speciation of zinc.  Red and green dashed lines demonstrate 
two possible cathodic reactions, oxygen reduction (oxygen dissolved in water in equilibrium 
with water) and hydrogen ion reduction (water in equilibrium with gaseous hydrogen), 
respectively.  The orange arrow shows the range of biological standard reduction potentials at pH 
7.0: from ~820 mV to ~ -670 mV. 
 
Figure 2. The pH dependence of five zinc aqua-hydroxo complexes in water solution.  a) Molar 
fraction distribution of particular zinc species as a function of pH.  b) Logarithmic plot of the 
concentration of particular species [17].  Black, red, green, blue and magenta color lines 
correspond to [Zn(H2O)x]2+, [Zn(OH)(H2O)x-1]+, [Zn(OH)2(H2O)x-2](aq), [Zn(OH)3(H2O)x-3]-, and 
[Zn(OH)4]2-, respectively. 
 
Figure 3. The pH dependence of the solubility of zinc hydroxide (ε-Zn(OH)2(s)) [20].  The 
ordinate indicates on a logarithmic scale the sum of all zinc soluble species present at a particular 
pH (Zn2+(aq)) which include aquo- and hydroxocomplexes presented in Figure 2.  The dashed line 
indicates the -log[Zn2+(aq)] value at pH 7.4. 
 
Figure 4. The zinc binding abilities of biological anions.  The bars demonstrate percentages of 
free and complexed species, calculated for 0.1 M anion and 1 µM of total Zn2+.  Light and dark 
grey colors refer to free and bound Zn(II) species, respectively.  
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
41 
 
 
Figure 5. The dependence of the dissociation constant of the [Zn(EDTA)]2- complex on 
experimental conditions used for its determination such as pH (a), ionic strength, I (b) and 
temperature (c).  Red, black and blue colors in b) and c) corresponds to pH 7.0, 7.4 and 8.0, 
respectively. 
 
Figure 6. Examples of structures of zinc complexes with low molecular weight biological 
ligands. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 1. Concentrations of simple biological and inorganic anions and stepwise formation constants for zinc anion complexes. Data refer to 25 
°C and I = 0.1 M unless otherwise specified. 
Anion Cell (mM) Blood (mM) Zn(II) complex formation logK Reference 
ClO4- n.d. n.d. [Zn(H2O)x]2+ + ClO4-    [Zn(ClO4)(H2O)x-1]+ -1.58 [96] 
NO3- n.d. n.d. [Zn(H2O)x]2+ + NO3-    [Zn(NO3)(H2O)x-1]+ -0.12 [97] 
Cl- 4 116 [Zn(H2O)x]2+ + Cl-   [ZnCl(H2O)x-1]+ 
[ZnCl(H2O)x-1]+ + Cl-   [ZnCl2(H2O)x-2] 
[ZnCl2(H2O)x-2] + Cl-   [ZnCl3(H2O)x-3]- 
[ZnCl2(H2O)x-3] + Cl-   [ZnCl4]2- 
0.43a 
0.18a 
-0.1a 
-0.31a 
[98, 99] 
 
HCO3- 12 29 [Zn(H2O)x]2+ + HCO3-   [Zn(HCO3)(H2O)x-1]+ 
[Zn(H2O)x-1]2+ + CO32-   [Zn(CO3)(H2O)x-1](aq) 
0.85b 
3.3a 
[98, 100] 
OAc- n.d. n.d. [Zn(H2O)x]2+ + OAc-    [Zn(OAc)(H2O)x-1]+ 0.93 [101] 
SO42- 0.3 0.27 (serum) [Zn(H2O)x]2+ + SO42-    [Zn(SO4)(H2O)x-1] 2.34c [102-104] 
Pi (pKa = 7.21)d 0.5–5 0.8–1.5 [Zn(H2O)x]2+ + HPO42-    [Zn(HPO4)(H2O)x-1](aq) 2.4 [95-107] 
HS- 15 nM n.d. [Zn(H2O)x]2+ + HS-   [Zn(HS)(H2O)x-1]+ 
[Zn(HS)(H2O)x-1]+  + HS-   [Zn(HS)2(H2O)x-2](aq) 
6.1e 
4.1e 
[108, 109] 
 
HO- 0.1 µM n.d. [Zn(H2O)x]2+ + OH-   [Zn(OH)(H2O)x-1]+ 
[Zn(H2O)x-1]2+ + OH-   [Zn(OH)(H2O)x-2](aq) 
[Zn(OH)2(H2O)x-2](aq) + OH-   [Zn(OH)3(H2O)x-3]- 
[Zn(OH)3(H2O)x-3]2+ + OH-   [Zn(OH)4]2- 
4.95f 
4.25f 
3.9f 
3.5f 
[22] 
a
 I = 0 M, b I = 0.68 M, c I is unknown, d Pi refers to inorganic phosphate, which in water medium is H2PO4- in equilibrium with HPO42-, pKa corresponding to H2PO4- 
dissociation is 7.21 [107], e I = 0.72 M, n.d. – not determined.  
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Table 2. The apparent dissociation constants and competitivity indices (CI)a of zinc complexes with common chemicals and natural products. 
Unless otherwise specified, the stability values were determined at pH 7.4, I = 0.1 M and 25 °C.  
Liga-
nds 
zinc ligand Complex 
stoichiometryb 
Donors c Apparent dissociation 
constant (Kd) 
pKd Competitivity Index  
(-logCI)a 
References 
 
p
H
 
b
u
f
f
e
r
s
 
Tris ZnL NO* 3.29 × 10-2 M 1.48 1.48 [110] 
Bis-Tris ZnL NO* 5.03 × 10-3 M 2.30 2.30 [111] 
Bis-Tris propane ZnL,  NO* 1.19 × 10-4 M 2.93 3.32 [112] 
ZnL2 N2O2* 2.15 × 10-6 M2 5.66 
Bicine ZnL  NO* 7.50 × 10-5 M 4.12 4.39 [88] 
ZnL2 N2O2* 3.12 × 10-7 M2 6.51 
Tricine ZnL NO* 6.47 × 10-5 M 4.19 4.19 [89] 
R
e
d
u
c
t
a
n
t
s
 
TCEP ZnL O3P 3.29 × 10-3 M 3.29 3.29 [93] 
β-
Mercaptoethanol 
Zn2L3-Zn6L15 S2-S4 
(S4) 
n.c. n.c. 3.60d [92] 
DTT ZnL2, Zn3L4 
(ZnL) 
S4 (S4) 2.83 × 10-10 M2 9.55 8.32 [90] 
DTBA ZnL2 (ZnL, 
Zn2L3) 
S4 (S4) 5.38 × 10-13 M2 12.27 9.29 [91] 
C
a
r
b
o
x
y
l
i
c
 
a
c
i
d
s
 α-Ketoglutaric 
acid 
ZnL, ZnL2 O2, O4 ~2 × 10-2 M2 ~1.7 1.13d [113] 
Pyruvic acid 
(pyruvate) 
1:1, 1:2 O2, O4 ~ 2 × 10-3 M2 ~2.0 1.26d [114] 
Succinic acid 
(succinate) 
ZnL O2 2.54 × 10-2 M 1.60 1.60 [115] 
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Glutaric acid 
(glutarate) 
ZnL O2 2.52 × 10-2 M 1.60 1.60 [115] 
Lactic acid 
(lactate) 
ZnL O2 1.38 × 10-2 M 1.86 1.86 [116] 
Lipoic acide ZnL O2 3.7 × 10-3 M 2.43 2.43 [117] 
Malic acid 
(malate) 
ZnL O2 1.52 × 10-4 M 3.82 2.82f [118] 
Folic acid 
(folate) 
ZnL2 N2O2 2.2 × 10-6 M2 5.67 2.84g [119] 
Oxalic acid 
(oxalate) 
ZnL O2 3.16 × 10-4 M 3.50 3.50 [120] 
Orotic acid 
(orotate) 
ZnL NO 2.20 × 10-4 M 3.66 4.80f [121] 
ZnL2 N2O2 2.40  × 10-8 M2 7.62 
Dipicolinic acid ZnL NO2 5.74 × 10-4 M 3.24 8.70h [122] 
ZnL2 N2O4 1.33 × 10-12 M2 11.88 
Citric acid 
(citrate) 
ZnL2 (ZnL) O6 (O6) 1.17 × 10-12 M2 11.93 8.76 [41] 
A
m
i
n
o
 
a
c
i
d
s
 
Glutamic acid 
(glutamate)  
ZnL NO 2.85 × 10-3 M 2.54 2.70 [66] 
ZnL2 N2O2 2.18 × 10-5 M2 4.66 
Glycine ZnL  NO 2.40 × 10-3 M 2.62 2.82 [87] 
ZnL2 N2O2 1.29 × 10-5 M2 4.89 
Aspartic acid 
(aspartate) 
ZnL NO 3.92 × 10-4 M 3.40 3.54 [44] 
ZnL2 N2O2 4.13  × 10-6 M2 5.38 
N-Ac-Cys ZnL2 (ZnL) 
 
O2S2 (OS) 6.77 × 10-8 M2 7.17 4.06 [123] 
Histidine ZnL N2O 3.22 × 10-4 M 3.49 5.48 [40] 
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ZnL2 N4O2 3.05 × 10-9 M2 8.52 
Cysteine ZnL2 (ZnL) N2S2 (NS) 9.77 × 10-12 M2 11.01 7.84i [124] 
D-penicillamine ZnL2 (ZnL) N2S2 (NS) 2.81 × 10-12 M2 11.55 8.38i [124] 
N
u
c
l
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 AMP ZnL NO 1.84 × 10-3 M 2.73 2.73 [125] 
ADP ZnL NO2 9.73 × 10-5 M 4.38 4.38 [125] 
ATP ZnL NO3 7.68 × 10-6 M 5.11 5.11 [125] 
R
e
d
o
x
 
b
u
f
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GSSG ZnL (Zn2L) N2O2 
(NO) 
5.3 × 10-5 M 4.28 4.28 [66] 
GSH ZnL NOS 1.65 × 10-4 M 3.78 5.16 [126] 
ZnL2 NOS2 8.74 × 10-9 M2 8.06 
Bacillithiol ZnL  NSO2* 4.0 × 10-6 M 5.40 9.05j [73] 
ZnL2 N2S2* 5.38 × 10-13 M2 12.27 
O
t
h
e
r
s
 
Tetracycline  ZnL O2 6.77 × 10-3 M 2.17 2.17f [127] 
Carnosine ZnL NO 4.55 × 10-3 M 2.34 2.34 [128] 
Oxytetracycline ZnL O2 2.24 × 10-3 M 2.65 2.65f [127] 
Diphosphate 
(pyrophosphate) 
ZnL O2 1.91 × 10-3 M 2.72 2.72 [32] 
Gentamicin C1a 1:1 NO* 1.60 × 10-3 M 2.79 2.79 [129] 
Histamine ZnL  N2 2.98  × 10-3 M 2.53 2.96 [130] 
ZnL2 N4 5.41 × 10-6 M2 5.27 
Triphosphate ZnL O3 1.35 × 10-7 M 6.87 6.87 [33] 
Tetraphosphate ZnL O4* 5.72 × 10-8 M 7.24 7.24 [34] 
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Pyrithione ZnL2 k (ZnL) O2S2 k 
(OS) 
5.0 × 10-12 M2 11.30 8.30 [76] 
Phytic acid 
(phytate) 
ZnL O5* 3.7 × 10-11 M 10.44 10.44 [35] 
Nicotianamine ZnL N3O3 1.60 × 10-11 M 10.48 10.48 [82, 131] 
 
a
 CI is the apparent dissociation constant of ZnZ complex (zinc complex of theoretical molecule Z), such that [ZnZ] = Σijk [ZniHjLk], at a given overall component concentration.  The 
concentrations of disulfide reductants and Z were set at 2 mM, and those of Zn2+ at 0.5 mM. b Complexes in brackets are present in minority. c Donors in brackets refer to complex as minor 
species. d I = 0.5 M. e 37 °C, I = 0.15 M. e Dihydrolipoic acid (reduced form of lipoic acid) is assumed to bind Zn2+ more tightly. g 20 °C, I = 0.01 M. h 20 °C, i I = 0.2 M. j Apparent dissociation 
constant determined at pH 7.7, I = 0.15 M. k Complex in crystals present as dinuclear Zn2L4 species with S3O2 donors. n.c. – not calculated. Asterisks denotes putative donor atoms.  
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Table 3. The apparent dissociation constantsa of zinc complexes with widely used zinc chelators and fluorogenic or chromophoric probes with 
pZn ranges of their application.b Unless otherwise specified, the stability values were determined at pH 7.4, I = 0.1 M and 25 °C. Stoichiometry 
is simplified to ZnLx without protonation state. 
 Chelator / probe Donors Complex 
stoichiometry 
Apparent dissociation 
constant (Kd)  
-log Kd  
(pKd) 
pZn range of the 
application 
References 
Z
i
n
c
 
c
h
e
l
a
t
o
r
s
 
TPEN N6 ZnL 6.4 × 10-16 M 15.2 14.2 – 16.2 [44] 
DTPA N2O4 ZnL 5.62 10-15 M 14.3 13.3 – 15.2 [44] 
 EDTA N2O4 ZnL 2.3 × 10-14 M 13.6 12.7 – 14.6 [44] 
HEDTA N2O3 ZnL 6.6 × 10-13 M 12.2 11.2 – 13.1 [44] 
EDDSc N2O4 ZnL 2.3 × 10-11 M 10.6 9.7 – 11.6 [44] 
BAPTA N2O4 ZnL 4.9 × 10-10 M 9.3 8.4 – 10.3 [132] 
EGTA N2O4 ZnL 6.3 × 10-10 M 9.2 8.2 – 10.2 [44] 
EDDA N2O2 ZnL 1.2 × 10-9 M 8.9 8.0 – 9.9 [44] 
NTA NO3 ZnL 4.4 × 10-9 M 8.4 7.4 – 9.3 [133] 
Cyclamd N4 ZnL 2.0 × 10-9 M 8.7 7.5 – 9.5 [134] 
IDA NO2 ZnL  3.2 × 10-5 M 8.3 5.3 – 6.8 [135] 
N2O4 ZnL2 4.8 × 10-9 M2 4.5 
F
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FluoZin-3 N2O3 ZnL 8.9 × 10-9 M 8.1 7.1 – 9.0 [9] 
RhodZin-3 N2O3 ZnL 1.4 × 10-9 M 8.9 7.9 – 9.8 [136]  
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ZnAF-1 N4 ZnL 7.8 × 10-10 M 9.1 8.2 – 10.1 [137]  
ZnAF-2 N4 ZnL 2.7 × 10-9 M 8.6 7.6 – 9.5 [137] 
ZnAF-1F N4 ZnL 2.2 × 10-9 M 8.7 7.7 – 9.6 [137] 
ZnAF-2F N4 ZnL 5.5 × 10-9 M 8.3 7.3 – 9.2 [137] 
Zinpyr-1e N3O ZnL 7 × 10-10 M 9.2 8.2 – 10.1 [138] 
Zinpyr-4e N4 ZnL 6.5 × 10-10 M 9.2 8.2 – 10.1 [139] 
NBD-TPEAf N5 ZnL 2 × 10-9 M 8.7 7.8 – 9.7 [140] 
Zinbo-5f N3O ZnL 2.2 × 10-9 M 8.7 7.7 – 9.6 [141] 
Fura-2f N2O4 ZnL 3 × 10-9 M 8.5 7.5 – 9.4 [142] 
Mag-Fura-2 NO3 ZnL 2 × 10-9 M 8.7 7.7 – 9.6 [143] 
NewPort Green 
DCFg 
N3 ZnL 1 × 10-6 M 6.0 5.1 – 6.9 [144] 
NewPort Green 
PDXe 
N3 ZnL 4 × 10-5 M 4.4 3.9 – 5.4 [145] 
Zinquinh N4 ZnL 3.7 × 10-7 M 6.4 7.0 – 9.3 [146] 
ZnL2 8.5 × 10-13 M2 13.1 
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h
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Zincon N2O2 ZnL 1.3 × 10-5 M 4.9 4.2 – 5.9 [147] 
PAR N2O ZnL  2.75 × 10-5 M 4.6 7.28 – 9.4 [148] 
N4O ZnL2 7.08 × 10-13 M2 12.2 
 
a
 Dissociation constants of ZnL and ZnL2 are defined as [Zn2+][L]/[ZnL] and [Zn2+][L]2/[ZnL2], respectively.  b The pZn range for application of a particular chelator/probe refers to free zinc 
values (-log[Zn2+]free) corresponding to 0.9 mM : 1 mM – 0.1 mM : 1 mM molar ratio (Zn2+ : L) range.   For IDA the application range refers to 0.45 mM : 1 mM – 0.05 mM : 1 mM molar ratio 
range. In case of zinquin and PAR the pZn range corresponds to 10 µM : 4.5 µM – 10 µM : 0.5 µM and 100 µM : 45  µM – 100 µM : 5 µM, respectively due to limited solubility and typical 
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range of use.  It should be noticed that the range of application for some probes is wider due to high increase of signal upon Zn2+ binding.  For those probes, free zinc below 10% of probe 
saturation can be measured. c T = 20 °C. d I = 0.2 M. e pH = 7.0, f pH = 7.5. g Experimental pH value unknown. h Data determined in HBBS buffer. 
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